ENDOMETRIAL CLEAR CELL ADENOCARCINOMA
Clinical trials for ENDOMETRIAL CLEAR CELL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL CLEAR CELL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL CLEAR CELL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced endometrial cancer: three-drug combos tested in major trial
Disease control OngoingThis study tested three different drug combinations in 349 people with advanced (stage III or IV) or recurrent endometrial cancer. The goal was to see which combination worked best at stopping the cancer from growing or spreading. Participants received either paclitaxel/carboplat…
Matched conditions: ENDOMETRIAL CLEAR CELL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC
-
Immunotherapy plus chemo shows promise for tough endometrial cancers
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy (paclitaxel and carboplatin) helps people with advanced or recurrent endometrial cancer live longer without the disease getting worse. About 800 participants with stage III, IV, or recur…
Matched conditions: ENDOMETRIAL CLEAR CELL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
New drug combo targets Hard-to-Treat brain tumors
Disease control OngoingThis early-phase study tests a new drug (MLN0128) combined with bevacizumab in 50 adults with recurrent glioblastoma or other advanced solid tumors. The goal is to find the safest dose and understand side effects. This is not a cure, but aims to control tumor growth.
Matched conditions: ENDOMETRIAL CLEAR CELL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 10, 2026 13:25 UTC
-
New scan and dye combo may spot hidden cancer in lymph nodes
Diagnosis OngoingThis study looks at whether combining a special scan (PET/CT) with a dye that highlights lymph nodes can better detect cancer spread in women with high-risk endometrial cancer. About 100 women scheduled for surgery will get both tests before their operation. The goal is to see if…
Matched conditions: ENDOMETRIAL CLEAR CELL ADENOCARCINOMA
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 16, 2026 23:07 UTC